This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Skeletal muscle reduces nearly 2% per day upon admission to intensive care
Read more
Combining respiratory SOFA and burn area score predict mortality in severe burn and inhalation injury
Read more
Screening-based predictive tools for COVID-19 in ED inferior to PCR test
Read more
Early emollient use among high-risk infants prevents atopic eczema
Read more
Fidanacogene elaparvovec gene therapy effective for haemophilia B
Read more
Herpes zoster infection linked to higher risk of stroke and coronary heart disease
Read more
Coronary artery calcium score and cystatin C level combined predict MACCE in chest pain
Read more
Drinking coffee and tea significantly reduces cardiovascular disease mortality
Read more
Higher lipoprotein A in hypertensives increases risk of adverse cardiovascular events
Read more
Glofitamab fast and effective in refractory mantle cell lymphoma
Read more
Meet the Expert: Philip Mease on psoriatic arthritis
Read more
CHMP recommends Enhertu for HER2-low breast cancer treatment
Read more
Significant placebo response to pain in cannabinoid clinical trials
Read more
Elranatamab induces durable clinical response in relapsed multiple myeloma
Read more
mRNA-4157/V940 vaccine effective in advanced melanoma
Read more
Review suggests GLP1 agonists offer similar glycaemic control to bariatric surgery
Read more
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Read more
Page 34 of 200
« First
«
...
10
20
...
32
33
34
35
36
...
40
50
60
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: